Poxel SA Receives CNIPA Patent for Imeglimin

Poxel SA, a biopharmaceutical firm at the clinical stage focusing on developing groundbreaking therapies for chronic serious diseases characterized by metabolic pathophysiology, such as metabolic dysfunction-associated steatohepatitis (MASH)...

Hoth Therapeutics Expands Intellectual Property with New Patents

Hoth Therapeutics, Inc., a biopharmaceutical firm centered on patients, is pleased to announce progress in its intellectual property holdings by acquiring and expanding patent applications related to its cutting-edge therapeutic pipeline...

US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter

Opella, the Consumer Healthcare division of Sanofi, announced that the US Food and Drug Administration (FDA) has removed a clinical hold on its proposed actual use trial (AUT) aimed at facilitating the transition of Cialis (tadalafil) from...

BioNxt Moves R&D to Munich's Gen-Plus CRDO for Drug Delivery Innovations

BioNxt Solutions Inc, a bioscience firm focused on cutting-edge drug delivery systems, is thrilled to share a significant achievement in its research and development progress. The firm is moving its innovative R&D tasks to the Gen-Plus Contract...

CCI Approves Merger of Nine Entities with Sequent Scientific

The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...

Glenmark Pharma Unveils generic anticoagulant injectable emulsion

Glenmark Pharmaceuticals announced that its US division has introduced the anticoagulant Phytonadione injectable emulsion. Glenmark Pharmaceuticals Inc., USA has introduced a 10 mg/mL injectable emulsion of Phytonadione in single-dose ampules...

InnoCare and KeyMed Bags Licensing Deal for Bispecific Antibody ICP-B02

InnoCare Pharma and KeyMed Biosciences announced that they, along with their joint venture, have collectively signed an exclusive licensing agreement with Prolium Bioscience (Prolium) for the advancement and marketing of ICP-B02 (CM355)...

GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer

GSK plc announced that the European Commission has authorized Jemperli (dostarlimab) in conjunction with chemotherapy (carboplatin and paclitaxel) as a first-line therapy for adult patients with primary advanced or recurrent endometrial cancer...

SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety

SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in...

Indian Pharma Experts Expect Boost in Trade with Trump's US Presidency

Indian pharmaceutical experts anticipate positive trade conditions with Donald Trump assuming the presidency of the US. The United States continues to be an important market for Indian pharmaceutical firms, representing roughly 30% of India's...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.